- Home
- CRBP vs GMGI Comparison
CRBP vs GMGI Comparison
Compare CRBP & GMGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRBP | GMGI |
|---|---|---|
| Founded | 2009 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 134.8M | 115.8M |
| IPO Year | 2014 | 2008 |
Fundamental Metrics
Financial Performance| Metric | CRBP | GMGI |
|---|---|---|
| Price | $7.63 | $0.51 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 1 |
| Target Price | ★ $50.29 | $4.00 |
| AVG Volume (30 Days) | 138.7K | ★ 207.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 64.31 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $4,822,272.00 | ★ $151,115,532.00 |
| Revenue This Year | N/A | $25.59 |
| Revenue Next Year | $220.00 | $14.27 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 97.62 | 62.50 |
| 52 Week Low | $4.64 | $0.51 |
| 52 Week High | $20.56 | $2.21 |
Technical Indicators
Market Signals| Indicator | CRBP | GMGI |
|---|---|---|
| Relative Strength Index (RSI) | 43.45 | 32.24 |
| Support Level | $6.73 | N/A |
| Resistance Level | $8.43 | $0.74 |
| Average True Range (ATR) | 0.47 | 0.06 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 38.50 | 0.14 |
Price Performance
Historical ComparisonAbout CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
About GMGI Golden Matrix Group Inc.
Golden Matrix Group Inc is an established gaming technology company. The company develops and owns online gaming IP and builds configurable and scalable white-label social gaming platforms for its international customers. The company operates in three reportable segments; MeridianBet Group, GMAG, RKings & CFAC. The MeridianBet Group segment earns majority revenue. The company operates in UK, Europe, Asia Pacific, Central and South America, Australia and Africa. It offers configurable and scalable iGaming platforms and operate some of the industry's iconic brands, including MexPlay, GM-AG, and others.